Ardelyx (ARDX) Gross Profit Growth (3y) (2018 - 2026)
Ardelyx (ARDX) Gross Profit Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 54.36% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 7.16% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 3.86% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 79.18% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Ardelyx | 1.26 Bn | 1.02 Bn | 89.66 Mn | 108.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 108.92% |
| Dec 31, 2025 | 40.75% |
| Sep 30, 2025 | -28.80% |
| Jun 30, 2025 | 229.28% |
| Mar 31, 2025 | 444.45% |
| Dec 31, 2024 | 356.46% |
| Sep 30, 2024 | 312.80% |
| Jun 30, 2024 | 264.88% |
| Mar 31, 2024 | 91.00% |
| Dec 31, 2023 | 153.16% |
| Sep 30, 2023 | 161.83% |
| Jun 30, 2023 | 123.19% |
| Mar 31, 2023 | 100.88% |
| Dec 31, 2022 | 163.18% |
| Sep 30, 2022 | 20.80% |
| Jun 30, 2022 | 410.02% |
| Mar 31, 2022 | 33.57% |
| Dec 31, 2021 | 129.61% |
| Sep 30, 2021 | 90.38% |
| Jun 30, 2021 | 252.41% |